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T
he clinical success of oral im-
plants depends on minimizing
the amount of marginal bone
loss after several years of functional
loading.1–3 In most studies, treatment
outcome has been determined for each
implant system individually with vari-
ous follow-up periods and established
for particular follow-up parameters.4
There have also been some compara-
tive studies on different implant sys-
tems with different implant surface
properties.5,6 Surface topography and
roughness of the titanium may have
a signiﬁcant effect on the host
response to the implant. Rough surface
topography seems to allow close con-
tact with blood clots permitting migra-
tion and differentiation of precursor
osteogenic cells, which are responsible
for bone formation directly at the
implant surface. One study showed
that implants with a rough surface
exhibit a greater bone-to-implant con-
tact (BIC) rate compared with implants
having a polished surface.7 Another
study found that the surface chemistry
and its wettability is another important
factor affecting periimplant bone
apposition by improving early contact
between the implant surface and the
biological environment.8
Most recently, a chemically modi-
ﬁed, sand-blasted, large grit and, acid-
etched (SLActive) titanium surface has
been designed with the aim of enhancing
bone apposition.9 The speciﬁc produc-
tion method used for modSLA surfaces
aimed to create a chemically active sur-
facewith a small amountof hydrocarbons
and carbonates. This hydroxylated/
hydrated modSLA surface was revealed
to have an initial advancingwater contact
angle of 0°, indicating its immediate wet-
tability and ultra-hydrophilic character.
The chemical modiﬁcation of the
implant surface such as the modiﬁed
SLA-surfaced (modSLA) implants can
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Purpose: The aim of this study
was to compare marginal bone loss
around early-loaded SLA and SLAc-
tive tissue-level implants (Straumann
Dental Implants; Institut Straumann
AG, Basel, Switzerland) after a mean
of 81-month follow-up period.
Material and Methods: One
hundred seven SLA and 68 SLActive
implants were placed in 55 patients
and loaded with ﬁnal restoration
after 8 and 3 weeks of healing time,
respectively. Marginal bone loss
around implants was determined
radiographically at initial and after
a mean observation time ranging
between 20 and 81 months. The
effect of location (mandible vs max-
illa), smoking habit, sex, implant
length and diameter, and the type
of prosthesis on the marginal bone
loss was evaluated.
Results: The overall cumulative
survival rate was 98.2% being 99%
for SLA implants and 97% for
SLActive implants. After 20-month
follow-up period, mean marginal
bone loss values for the SLA and
SLActive implants were 0.24 and
0.17 mm, respectively. After 81
months, mean marginal bone loss
for the SLA and SLActive implants
reached 0.71 and 0.53 mm, respec-
tively. Marginal bone loss was
affected by the length and type of
implant and patients’ smoking habit
after a mean observation time of 20
months. However, none of the param-
eters had any signiﬁcant effect on the
marginal bone loss after a follow-up
period of 81 months.
Conclusion: With both SLA and
SLActive implants, successful clini-
cal results could be achieved up to
6.5 years of follow-up period.
(Implant Dent 2017;26:592–599)
Key Words: bone resorption,
implant length, smoking, survival
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transform a hydrophobic surface into
a hydrophilic surface, and thereby
induce nanorough surfaces. Numerous
studies demonstrated that the bone
response is inﬂuenced by the implant
surface topography and that rough
implant surfaces lead to a stronger BIC.
When the implant comes in contact with
blood, the hydrophilic behavior of the
(modSLA) surface becomes chemically
more reactive and an intimate condition-
ing layer is formed. The (SLActive)
implant has a greater BIC at 2 and 4
weeks compared with SLA surface.
Human and animal histologic studies
have also demonstrated that moderately
rough SLActive surface contributed to
an optimal osseointegration.10–12
Despite the fact that the relationship
between early osseointegration success
and modSLA surface has been clariﬁed,
it remains to be investigated whether
there is a relationship between marginal
bone loss of early loaded implants and
modSLA surface. The aim of this study
was to evaluate marginal bone loss
around the early-loaded SLA (SLA,
Straumann Dental Implants; Institute
Straumann AG, Basel, Switzerland)
and SLActive implants (SLActive,
Straumann Dental Implants) up to 6.5
years. The following hypothesis were
tested: SLActive implants would result
in less marginal bone loss than SLA
implants and that some implant and
patient-related parameters such as smok-
ing habits, sex, location (maxilla vs
mandible), implant length and diameter
would affect the marginal bone loss
around both types of implants.
MATERIALS AND METHODS
Selection Criteria for the Patients
Patients participating in the study
provided written, informed consent to
the treatment, and agreed to attend for
follow-up clinical visits, including
postoperative radiographs. All patients
were partially edentulous in the poste-
rior regions of the maxilla and/or man-
dible, displaying a single-tooth gap, an
extended edentulous space, or a distal
extension situation. The opposing den-
tition consisted of completely or par-
tially removable dentures, natural teeth
or implant-supported restorations. All
implantation regions required
a minimum of 4 months of healing time
after tooth extraction (Table 1).
The medical history of each patient
was evaluated at the initial and recall
examinations, and only healthy patients
were included in the study. Patients
with certain systemic diseases, such as
diabetes mellitus and osteoporosis,
were included in the study. Smoking
and bruxismwere recorded butwere not
considered as a contraindication to
treatment. Patients were informed that
smoking is associated with an increased
risk of implant failure. Before insertion
Table 1. Distribution of Patients, Implants, and Restorations According to Study
Parameters (Sex, Age, and Smoking Habit of Patient, Implant Type, Length and
Diameter, Type of Restoration, and Jaw Type)
Patients
Sex Age Smoking habit
Male Female Mean Range Nonsmoker Smoker
34 21 50 20–65 33 22
Implants
Type Location Diameter Length
SLA SLActive Maxilla Mandible ,4 mm .4 mm ,10 mm .10 mm
107 68 77 98 82 93 23 152
Restoration Fixed Prosthesis
Single
Short Bridge
(3 or Fewer)
Long Bridge
(More Than 3)
66 35 13
Table 2. Mean Marginal Bone Loss Values (mm) and SDs According to Study
Parameters (Sex, Age, and Smoking Habit of Patient, Implant Type, Length and
Diameter, Type of Restoration, and Jaw Type) After 20- and 81-Mo Follow-Up
Periods
Marginal Bone Loss (mm)
20 Mo 81 Mo
Mean 6 SD P Mean 6 SD P
Implant type
SLA 0.24 6 0.17 0.001* 0.71 6 0.35 0.206
SLActive 0.17 6 0.16 0.53 6 0.28
Sex
Male 0.23 6 0.18 0.059 0.72 6 0.45 0.208
Female 0.19 6 0.17 0.54 6 0.27
Smoking habit
No smoking 0.17 6 0.11 0.000* 0.53 6 0.27 0.079
Smoking 0.26 6 0.21 0.77 6 0.37
Jaw
Mandible 0.21 6 0.19 0.842 0.69 6 0.45 0.739
Maxillae 0.21 6 0.16 0.61 6 0.32
Implant length
.10 mm 0.16 6 0.11 0.028* 0.42 6 0.19 0.221
,10 mm 0.22 6 0.18 0.68 6 0.47
Implant diameter
,4 mm 0.20 6 0.16 0.324 0.56 6 0.29 0.525
.4 mm 0.22 6 0.19 0.71 6 0.44
Type of prosthesis
Single 0.20 6 0.18 0.166 0.75 6 0.45 0.439
Short bridge (3 or fewer) 0.20 6 0.15 0.59 6 0.30
Long bridge (more than 3) 0.24 6 0.20 0.53 6 0.28
*P , 0.05.
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of the implants, patients underwent
examinations to evaluate any periodon-
tal disease, caries, and soft tissue disor-
der. They also received appropriate
treatment and oral hygiene instruction.
Panoramic radiographs were obtained
before implant insertion.
Surgical and Prosthetic Procedures
Surgery was performed under local
anesthesia following the standard
Straumann one-stage surgery protocol.
A crestal incision was made and full-
thicknessﬂapswere raised. The implant
was placed in the recipient site using an
insertion device and a hand ratchet or
motor drive. Any patient with implants
lacking primary stability or with inad-
equate bone at surgery was excluded
from further participation in the study.
Healing abutments were inserted for
transmucosal healing. Sutures were
removed 1 to 2 weeks after surgery.
Patients were treated with an antibiotic
regimen consisting of 500 mg amoxi-
cillin twice daily for 5 days starting 1
hour before surgery. They were in-
structed to rinse with a 0.1% chlorhex-
idine solution twice a day for 1 or 2
weeks until suture removal. Analgesics
were given as required for pain control.
None of the patients wore any pro-
visional prosthesis during the osseoin-
tegration period.
Thirty-ﬁve International Team for
Implantology (ITI) SLActive implants
(51.5%) were placed in the mandible
and 33 (48.5%) in the maxilla, whereas
63 SLA implants (58.9%) were placed
in the mandible and 44 (41.1%) in the
maxilla. Group I consisted of 107 SLA
implants loaded after 8 weeks’ healing
time and Group II consisted of 68
SLActive implants loaded after 3weeks
of healing time.
All patients received ﬁxed dental
prosthesis (FDP). The distribution of
restorations was as follows: three-unit
FDPs in the maxilla or mandible (11
patients, 70 implants), single-tooth
crowns in the maxilla or mandible (38
patients, 66 implants), and multiple-
unit FDPs in the maxilla or mandible
(6 patients, 39 implants).
After a healing period of 3 weeks
in the SLActive implant group, the
patients were recalled for restorative
treatment. The prosthetic procedures
initially involved making an impres-
sion using the closed-tray technique
with a polyether impression material.
Permanent metal-porcelain FDPs were
cemented 3 or 4 weeks after surgery. In
the SLA implant group, ﬁnal metal-
porcelain FDPs were placed after
a healing period of 8 weeks.
Clinical and Radiographical
Examination
Standardized digital panoramic ra-
diographs (Orthophos XG; Sirona Den-
tal Systems, Bensteim, Germany) were
obtained ﬁrstly at the time of implant
placement and at a mean of 20 and 81
months after loading to calculate the
changes in bone level at the mesial and
the distal sites of the implants. The
distance from the implant shoulder to
the ﬁrst BIC was measured to calculate
the marginal bone loss by a single
independent calibrated examiner. The
anatomical magniﬁcation and distortion
Fig. 1. A and B, Radiographs of SLA implants after a mean observation period of (A) 26-
month follow-up period and (B) 85-month follow-up periods. Note the marginal bone loss after
85 months in Figures 1B and 2B.
Fig. 2. A and B, Radiographs of SLA implants after a mean observation period of (A) 26-
month follow-up period and (B) 85-month follow-up period. Note the marginal bone loss after
85 months in Figures 1B and 2B.
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of the radiographs was calibrated in
accordance with the clinical data (height
and width) for each implant and known
distance between 2 implant threads. A
simple mathematical calculation was
done to calibrate and recalculate each
linear marginal bone loss measurement
according to the radiographic image
size.13 Marginal bone loss was com-
pared between the 2 groups according
to the following parameters: implant
diameter and length, sex of the patients,
unit numbers of prosthesis, location of
the implants (maxilla vs mandible) and
smoking habit of the patients (Table 2).
Implant success was deﬁned ac-
cording to Buser et al14 as absence of
(a) persistent pain, foreign body sensa-
tion, and/or dysesthesia; (b) recurrent
periimplant infection with suppuration;
(c) implant mobility; and (d) continuous
radiolucency around the implant.
Statistical Analysis
Implant survival curves were cal-
culated according to the product-limit
method (Kaplan-Meier algorithm).
Time zero was deﬁned as the date of
initial placement of the implant. Sur-
viving implants were included in the
total number with a risk of failure only
up to the time of their last follow-up
examination. Therefore, the success
rate changed only when a failure
occurred. Statistical analysis was per-
formed using SPSS Statistics software
package (IBM SPSS Inc., Chicago, IL).
Descriptive statistics (mean, range, and
SDs) were based on measurements
obtained from the implants. The bone
loss value in the 2 groupswas compared
statistically by means of one-way
ANOVA. P, 0.05 was considered sta-
tistically signiﬁcant for all tests.
RESULTS
Table 1 shows the distribution of
patients, implants, and restorations. A
total of 55 patients, 34 males, and 21
females received 107 SLA implants
and 68 SLActive implants. The age of
the patients ranged between 20 and 65
years. The number of nonsmoker pa-
tients was higher than the number of
patients who smokein the study group.
Ninety-eight implants were placed in
the maxilla and 77 implants in the man-
dible. The bone sink depth of the im-
plants ranged between 6 and 14 mm,
and the diameters between 3.3 and
4.8 mm in different areas. Diameter of
the placed implants was less than 4 mm
in 82 implants and more than 4 mm in
93 implants. The number of implants
longer than 10mm in length constituted
more than two thirds of the total im-
plants placed. The number of single
implant restoration was approximately
more than half of the total restored
implants.
All implants were osseointegrated.
However, 2 male patients and 1 female
patient who were heavy smokers lost
their implants after 73, 50, and 68
months, respectively. One SLA- and
2 SLActive-failed implants were
$10 mm long and $4.1 mm diameter
and restored with single and 3 unit
FDPs, respectively. All of these im-
plants were removed because of the
periimplantitis and mobility. The over-
all cumulative survival rate was 98.2,
being 99% for SLA implants and 97%
for SLActive implants.
Table 2 presents mean marginal
bone loss values of the implants accord-
ing to the study parameters after a mean
of 20- and 81-month follow-up periods.
The mean change in the bone level
was 0.24 6 0.17 mm for the SLA and
0.17 6 0.16 mm for the SLActive im-
plants after a mean of 20-month follow-
up, showing a signiﬁcant difference
between the 2 groups (P, 0.001).After
a mean of 81 months, mean marginal
Fig 3. A and B, Radiographs of SLActive implants after a mean observation period of (A) 21-
month follow-up period and (B) 82-month follow-up period. Note the marginal bone loss after
82 months in Figures 3B and 4B.
Fig. 4. A and B, Radiographs of SLActive implants after a mean observation period of (A) 21-
month follow-up period and (B) 82-month follow-up period. Note the marginal bone loss after
82 months in Figures 3B and 4B.
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bone loss was 0.71 6 0.35 and 0.53 6
0.28 mm for SLA and SLActive im-
plants, respectively. However, differ-
ence between the groups was not
statistically signiﬁcant (P . 0.05)
(Figs. 1–4).
The mean marginal bone loss was
0.23 6 0.18 mm and 0.19 6 0.17 mm
after a mean of function of 20 months,
and 0.72 6 0.45 and 0.54 6 0.27 mm
after a mean of 81 months in the male
and female groups, respectively. The
difference between the groups was not
statistically signiﬁcant at both follow-
up periods (P. 0.05).
The mean marginal bone loss was
0.17 6 0.11 mm and 0.26 6 0.21 mm
after a mean of 20 months, and 0.53 6
0.27 mm and 0.77 6 0.37 mm after
a mean of 81 months in nonsmoker
and smoker groups, respectively.
Smoking habit signiﬁcantly affected
the marginal bone loss around the im-
plants in the 20-month follow-up period
(P , 0.05). However, no statistically
difference was found in marginal bone
loss between smoker and nonsmoker
groups after a mean of 81 months.
Mean marginal bone loss did not
signiﬁcantly differ between the im-
plants placed in the mandible or in the
maxilla after a mean of 81 months (P.
0.05). The diameter of implants did not
have any effect on the marginal bone
loss around the implants at both
follow-up periods. However, the loss
of marginal bone in implants longer
than 10 mm was signiﬁcantly less than
those implants shorter than 10mm, after
amean observation period of 20months
(P, 0.05).
The implants used consisted of 66
single tooth crowns, 35 with 3 unit or
fewer unit, and 13 with 4 or more unit
FDPs. The type of prosthesis did not
affect marginal bone loss around the
implants at both follow-up periods
(P . 0.05).
DISCUSSION
Conventional implant loading pro-
tocols recommend a 12-week or longer
period of undisturbed healing after
implant placement to minimize the risk
of complications.15 Much shorter resto-
ration periods have become more
widely accepted and practiced in recent
years, especially, as a result of reported
success rates, modiﬁcation of the
implant surfaces, patient demands for
esthetic, and functional restoration as
soon as possible after surgery.16–19
Experiments have demonstrated
that SLActive implants signiﬁcantly
inﬂuence cell differentiation and
growth factor production in vitro9 and
improve early stages of osseointegra-
tion in animals when compared with
SLA implants.20 These healing charac-
teristics have been investigated in
a human experimental study with SLA
and SLActive implants and improved
bone-to-implant contact was docu-
mented for SLActive implants surface
compared with SLA implants after 14
and 28 days.10
Oates et al21 reported an increase in
the implant stability after 2 weeks for
the SLActive implants and 4 weeks
for the SLA implants in a clinical study.
Another clinical study22 that compared
the SLA and SLActive implants re-
ported higher survival rate for the
SLA implants. In contrast, in one other
study,23 lower success rate was noted
for the SLA implants comparing SLAc-
tive implants in 3-year follow-up
period.
The clinical ﬁndings of 3 studies,
with 72 SLA implants after immediate
and early loading, 104 SLA implants,
and 106 SLA implants after early
loading, demonstrated favorable re-
sults, with 5-year success rates of
100%, 99%, and 99%, respectively.24–26
Another study also reported high suc-
cess rate for the SLA implants in peri-
odontally compromised patients in
10-year follow-upperiod.27 Furthermore,
2 studies reported high success rate for
the SLActive implants after a 3-year
period.28,29 One of the latest study with
40 SLActive short implants reported
100% survival rate at 5-year follow-up
period.30 Finally, a systematic review
published on SLA and SLActive im-
plants comparing the clinical results in
early and immediate loading protocols
reported survival rates of 95% and 97%,
respectively.31 The result of our study
showing 97% survival rate for SLActive
implants and 99% for SLA implants over
a period of 81 months demonstrated sim-
ilar survival rate to those of the previous
studies.
One clinical study showed that
marginal bone loss for immediate and
early loaded SLA implants were 0.016
0.18 mm, 0.08 6 0.31 mm after 1 year
and 0.46 0.24 mm and 0.86 0.19 mm
after 5- year follow-up period, respec-
tively.24 Another recent study28 com-
pared marginal bone loss around
immediate and early loaded SLA im-
plants in 36-month follow-up and re-
ported 0.88 6 0.82 mm marginal bone
loss in the immediate loading group and
0.57 6 0.84 mm in the early loading
group.
Two studies evaluated marginal
bone level changes with immediately
and early loadedSLActive implants and
reported that the overall mean bone
level changes were 0.90 6 0.90 and
0.81 6 0.89 mm in the immediately
loaded groups, 0.63 6 0.95 mm and
0.566 0.73mm in early loaded groups,
for 12- and 5-month follow-up periods,
respectively.32,33 However, in another
study,23 lower bone level change was
noted for SLActive implants, namely
a marginal bone loss of 0.12 mm after
3 years. In the present study, marginal
bone loss around SLA and SLActive
implants was 0.71 6 0.35 and 0.53 6
0.28 mm, respectively, after 81 months
of clinical examination. Although our
follow-up period was longer than pre-
vious studies, lower marginal bone loss
was observed for both SLA and SLAc-
tive implants. This may be the result of
some factors such as patient selection,
good oral hygiene, and location of the
restorations.
A comparative study of SLA and
SLActive implants reported that mar-
ginal bone loss in the loading stage was
0.22 6 0.06 and 0.18 6 0.05 mm and
after 1 year which was increased to
0.46 6 0.07 mm and 0.43 6 0.11 mm
for SLA and SLActive implants,
respectively.22 In the present study,
marginal bone loss around the SLAc-
tive implants was similar to the re-
ported values in former studies. A
recent comparative histological study
with SLA and SLActive implants con-
cluded that the use of an activated
implant surface did not increase
bone-to-implant contact compared
with conventional implants.34 In addi-
tion, a recent review which included
1394 SLA and 145 SLActive implants
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reported no signiﬁcant differences in
relation to implant loss or clinical param-
eters between the immediate/early load-
ing and delayed loading protocols.31
It is well known that in comparison
to the mandible because of a different
bone quality which is more trabecular
and softer in nature, maxilla as a loca-
tion limits the success rates, especially,
in immediate or early loading.35 Never-
theless, the location being either the
mandible or the maxilla, patient’s sex
did not show any statistical correlation
with mean marginal bone loss. These
ﬁndings are in agreement with the re-
sults reported by Carlson et al.36 and
Eliasson et al.37 However, one retro-
spective study involving 141 ITI im-
plants in 66 patients showed that the
survival and success rates of implants
placed in male patients and in the max-
illa were lower than those of the im-
plants placed in female patients and in
the mandible.38
Smoking also affects the compli-
cation rates of implants. Previous stud-
ies have shown that the failure rate of
implants in smokers is higher than in
nonsmokers.39,40 A recent study41
determined greater marginal bone loss
among smokers similar to numerous
previous studies.39,40,42,43 Lindquist
et al42 in a 10-year follow-up study of
mandibular implant-supported prosthe-
ses found that marginal bone loss was
greater in smokers than in nonsmokers
and correlated with the amount of ciga-
rette consumption. Two latest long-
term implant survival studies concluded
that smoking was signiﬁcantly related
to increased implant failure.44,45 Recent
gene study results supported the
hypothesis that some bone markers in
the alveolar tissue are modulated by
smoking, which could explain the neg-
ative impact of smoking on bone heal-
ing.46 In the present study, we found
that smokers had signiﬁcantly greater
mean periimplant marginal bone loss
along the follow-up period compared
with nonsmokers and all of the 3 pa-
tients who lost their implants were
heavy smokers.
Several previous studies demon-
strated that shorter implants tended to
fail signiﬁcantly more often after un-
covering and after loading than longer
implants.47–49Wenget al48 reported that
60% of all failed implants were short
(#10mm), and that the cumulative suc-
cess rate for these short implants was
signiﬁcantly lower than the cumulative
success rate for all implants. In a study
by Herrmann et al,49 a signiﬁcant cor-
relation was demonstrated between
shorter implants and failure rate. How-
ever, other studies found that the failure
rates of short implants were similar to
those of longer ones. This ﬁnding was
observed with 7-mm long implants
placed in partially dentate patients,50
7-mm long implants placed in the man-
dible, and when the 7-mm implant was
not the most distal in an FDP.51 More-
over, in other studies52–57 which pro-
vided data on implant length, this was
not reported as inﬂuencing the survival
rate. In the present study, the implant
length had a positive effect on marginal
bone loss in 20-month follow-up period
but this effect was no longer observed at
later follow-up time. Recently, similar
results also showed that implant length
had a positive inﬂuence on primary
implant stability but this inﬂuence was
no longer observed at later time points
of measurement.24
Ivanoff et al.58 reported failure rates
of 5%, 3%, and 18% for 3.75-, 4-, and
5-mm-diameter implants, respectively.
The lowest cumulative survival rates
were seen with 4- and 5-mm-diameter
implants placed in the mandible (84.8%
and 73%, respectively). On the other
hand, one study47 reported that the per-
centage failure for implants with diame-
ters .3 mm was higher at each stage
compared with those with a diameter
.4 mm. In other studies, implant failure
did not seem to be signiﬁcantly inﬂu-
enced by the diameter.51,56,57,59 As such,
in the study by Friberg et al,59 the failure
rates were 5.5%, 3.9%, and 4.5% for
3.75-, 4-, and 5-mm-diameter implants,
respectively. Bone loss around narrow-
diameter implants was within the same
limits as those reported around standard-
diameter implants. In our study, we also
found that the diameter of the implants
did not have a signiﬁcant effect on the
marginal bone loss around the implants.
In this study, the ﬁrst 20 months
were considered as a critical time
point for early failures and 80 months
which almost correspond to 6.5 years
as late failures. The lack of annual
measurements could be considered as
a limitation of this study, but, inter-
estingly, long-term results seemed to
offset the importance of parameters
that could affect the survival of im-
plants and implant-borne FDPs which
could be considered one important
outcome of this study.
Overall, the studies reported sim-
ilar outcomes for both SLA and SLAc-
tive surfaces, independent of the
loading protocol. It could be antici-
pated that the modiﬁed SLA surface
would demonstrate the same long-term
efﬁcacy as the regular SLA implants
because the 2 implant surfaces are
characterized by the same surface
topography. The surfaces differ only
in their surface chemistry and
hydrophilicity.31
CONCLUSIONS
Up to 20 months, implant type,
smoking, and implant length signiﬁ-
cantly affected the marginal bone loss,
but after a mean follow-up period of 81
months, the amount of marginal bone
loss was not affected by the diameter
and length of the implants, location
(maxilla vs mandible), length of the
restoration, and sex of the patients and
their smoking habits.
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